ASML Holding N.V. unveiled a €12 billion authorization for share repurchases in 2026, marking the largest buyback in the company’s history. This decision follows ASML’s record revenue and operating profit growth in 2025, as management seeks to reduce the outstanding share count by roughly 5% over the next 12 months. The program is expected to be executed through a combination of open-market purchases and privately negotiated transactions, with completion targeted before the end of the fiscal year 2026.

After a recent analyst review, 33 firms covering ASML issued an average recommendation of “Moderate Buy.” The breakdown includes 2 sell ratings, 6 holds, 21 buys and 4 strong buys. Notable research actions in the past six months include Evercore ISI’s reaffirmation of an outperform view, Barclays’ upgrade to overweight and Jefferies’ maintenance of a neutral stance. This diversity in outlook underscores both optimism around ASML’s EUV leadership and caution over potential semiconductor cyclicality.

In its first dividend announcement of 2026, ASML declared a quarterly payout of €3.1771 per share, representing a 69% increase from the prior distribution. The new dividend implies an annualized payout of €12.71 per share and reflects a payout ratio of approximately 24.6%. The record date is set for April 27, with payment scheduled for May 5, reinforcing ASML’s commitment to returning excess cash to shareholders while maintaining investment capacity for R&D and capacity expansion.

Institutional investors hold roughly 26.1% of ASML’s outstanding shares, with notable activity in late 2025 and early 2026. North Star Investment Management grew its position by nearly 69% in Q4, while Princeton Global Asset Management boosted its stake by 154% during the prior year. Smaller allocations by Manning & Napier and City Holding reflect selective buying at valuation inflection points. Overall, institutional inflows suggest a sustained belief in ASML’s technology leadership and long-term growth runway.